DrugPatentWatch Database Preview
Drugs in Development Information for Simtuzumab
Summary for Simtuzumab
| US Patents | 5 |
| International Patents | 152 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2011-06-01) |
| Vendors | 0 |
US Patents for Simtuzumab
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Simtuzumab | ➤ Sign Up | Compositions comprising oxo-derivatives of fatty acids and methods of making and using same | DS BIOPHARMA LIMITED (Dublin, IE) | ➤ Sign Up |
| Simtuzumab | ➤ Sign Up | Multispecific constructs | AbbVie Stemcentrx LLC (North Chicago, IL) | ➤ Sign Up |
| Simtuzumab | ➤ Sign Up | Anti-CD324 monoclonal antibodies and uses thereof | ABBVIE STEMCENTRX LLC (North Chicago, IL) | ➤ Sign Up |
| Simtuzumab | ➤ Sign Up | Treatment of NASH with gemcabene | Gemphire Therapeutics Inc. (Livonia, MI) | ➤ Sign Up |
| Simtuzumab | ➤ Sign Up | Compositions and methods for treating fibrotic disease | eFFECTOR Therapeutics, Inc. (San Diego, CA) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for Simtuzumab
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Simtuzumab | China | 107847477 | 2035-05-13 | ➤ Sign Up |
| Simtuzumab | European Patent Office | 3294282 | 2035-05-13 | ➤ Sign Up |
| Simtuzumab | Japan | 2018524274 | 2035-05-13 | ➤ Sign Up |
| Simtuzumab | World Intellectual Property Organization (WIPO) | 2016181221 | 2035-05-13 | ➤ Sign Up |
| Simtuzumab | Canada | 2900764 | 2033-02-08 | ➤ Sign Up |
| Simtuzumab | European Patent Office | 2954056 | 2033-02-08 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
